Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. [electronic resource]
Producer: 20151105Description: 1754-62 p. digitalISSN:- 1476-5551
- Adolescent
- Adult
- Aged
- Child
- Child, Preschool
- Female
- Follow-Up Studies
- Graft Survival
- Graft vs Host Disease -- drug therapy
- Hematologic Neoplasms -- complications
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Immunosuppressive Agents -- therapeutic use
- Infant
- Infant, Newborn
- Male
- Middle Aged
- Myeloablative Agonists -- adverse effects
- Neoplasm Staging
- Primary Graft Dysfunction -- drug therapy
- Prognosis
- Retrospective Studies
- Survival Rate
- Transplantation Conditioning -- adverse effects
- Transplantation, Homologous
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.